Marcel Konrad
Director of Finance/CFO at MEDEXUS PHARMACEUTICALS INC.
Net worth: 97 546 $ as of 2024-03-30
Profile
Marcel Konrad is currently the Chief Financial Officer at Medexus Pharmaceuticals, Inc. He previously worked as the Senior VP-Finance, Accounting & Controller at CareDx, Inc. from 2018 to 2021 and as the Chief Financial Officer at Santen, Inc. from 2013 to 2018.
Mr. Konrad holds an MBA from the University of San Diego and an undergraduate degree from École des Hautes Études Commerciales de Paris.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-12 | 80,021 ( 0.33% ) | 97 546 $ | 2024-03-30 |
Marcel Konrad active positions
| Companies | Position | Start |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Director of Finance/CFO | 2021-07-18 |
Former positions of Marcel Konrad
| Companies | Position | End |
|---|---|---|
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Director of Finance/CFO | 2018-06-30 |
| CAREDX, INC | Director of Finance/CFO | 2021-03-24 |
Training of Marcel Konrad
| University of San Diego | Masters Business Admin |
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CAREDX, INC | Health Technology |
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Marcel Konrad
